Participant accessibility and representativeness

DCTs have significant potential to reduce logistical barriers and improve accessibility. This can enable the participation of traditionally underserved populations, ensuring that findings are applicable to more segments of the population…

Retention

Retention in a clinical trial refers to the number or proportion of participants who complete the study through to the end. The ease of participation in a DCT may improve retention as continued participation may be more flexibly managed around…

Carbon footprint

It has been reported that the pharmaceutical industry is among the highest producers of greenhouse gas emissions. Carbon footprinting can be used to identify which elements of DCTs have the greatest impact on greenhouse gas emissions…

Economic insights

Data quality